BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu D, Qin S, Su D, Wang K, Huang Y, Huang Y, Pang Y. Metabolic Reprogramming of the Right Ventricle and Pulmonary Arteries in a Flow-Associated Pulmonary Arterial Hypertension Rat Model. ACS Omega 2022;7:1273-87. [PMID: 35036789 DOI: 10.1021/acsomega.1c05895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 He X, Jarrell ZR, Smith MR, Ly VT, Liang Y, Orr M, Go YM, Jones DP. Metabolomics of V(2)O(5) nanoparticles and V(2)O(5) nanofibers in human airway epithelial BEAS-2B cells. Toxicol Appl Pharmacol 2023;459:116327. [PMID: 36460058 DOI: 10.1016/j.taap.2022.116327] [Reference Citation Analysis]
2 Ma R, Cheng L, Song Y, Sun Y, Gui W, Deng Y, Xie C, Liu M. Altered Lung Microbiome and Metabolome Profile in Children With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease. Front Med 2022;9. [DOI: 10.3389/fmed.2022.940784] [Reference Citation Analysis]
3 Santos-gomes J, Gandra I, Adão R, Perros F, Brás-silva C. An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.924873] [Reference Citation Analysis]